Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 12/20 | 0.37 |
| ▸ | LMNA | P02545 | 6/20 | 0.37 |
| ▸ | HTT | P42858 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 7/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21008784 | 0.82 | MAPT (0.35) | MAPTLMNAHTTKDM4EHCRTR1 | |
| SCHEMBL21008868 | 0.81 | CNR1 (0.31) | — | |
| SCHEMBL11990876 | 0.80 | MAPT (0.41) | MAPTLMNAHTTKDM4EHCRTR1 | |
| SCHEMBL11990871 | 0.78 | MAPT (0.42) | MAPTLMNAKDM4EMEN1KMT2A | |
| SCHEMBL10128247 | 0.78 | MAOA (0.44) | MAPTLMNAHTTKDM4EMAOA | |
| SCHEMBL23056710 | 0.76 | HTT (0.49) | MAPTLMNAHTTKDM4EHCRTR1 | |
| SCHEMBL19754284 | 0.74 | CES1 (0.48) | MAPTLMNAHTTKDM4EHCRTR1 | |
| SCHEMBL23638904 | 0.73 | GAA (0.41) | MAPTLMNAHTTKDM4EHCRTR1 | |
| SCHEMBL24044001 | 0.73 | LMNA (0.40) | MAPTLMNAKDM4EAKR1B1MEN1 | |
| SCHEMBL20202031 | 0.73 | MAPT (0.39) | MAPTLMNAHTTKDM4EHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210363416-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT AND SYNTHESIZING METHOD THEREOF | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-11-25 | — | — | US | disclosed |
| US-11177442-B1 | Thermally activated delayed fluorescence material and organic light emitting diode display device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-11-16 | — | — | US | disclosed |
| US-20210336150-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177442-B1 | Thermally activated delayed fluorescence material and organic light emitting diode display device | CCND1, CCND2, TRPA1 | MAPT 580/4885LMNA 2286/4885HTT 4675/4885 |
| US-20210336150-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE | CCND1, CCND2, TRPA1 | MAPT 580/4885LMNA 2286/4885HTT 4675/4885 |
| US-20210363416-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT AND SYNTHESIZING METHOD THEREOF | HSF1, TBCA, CPSF7 | MAPT 2066/4885LMNA 2168/4885HTT 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.